Many stakeholders involved in developing medical solutions share a common end goal: to develop and launch new products that improve society's wellbeing.
Regulatory bodies must also ensure the safety and efficacy of new products. Their need for independence means they are not able to work directly with industry. However, a more efficient and effective regulatory system benefits everyone: patients, public bodies, and private partners alike. Improvements can speed up innovation, improve resource allocation, and protect the interests of everyone involved.
By providing a neutral platform for all stakeholders, the Escher project, Lygature fosters common ground, mediates conflicting interests, and facilitates scientific discussions. Our work helps to drive joint efforts towards an improved and innovation-friendly regulatory framework. We initiate and conduct our own research into regulatory and HTA (Health Technology Assessment) topics, and also take on third-party proposals. The objective is to promote faster and more efficient development of medicines and medical technology.
HI-NL is a multi-stakeholder infrastructure where patients, doctors, health care-providers, methodologists, CE-experts, entrepreneurs, insurers, investors and regulatory authorities all contribute to faster deliver better medical devices.
Goal: To become the leading public-private infrastructure working to stimulate the development and implementation of safe, valuable, affordable and cost-effective health innovations.